以反复贫血及腹痛为首发症状的一例Castleman病诊疗经过及文献复习
Diagnosis and Treatment Process of a Case of Castleman Disease with Recurrent Anemia and Abdominal Pain as the Initial Symptoms, along with a Literature Review
DOI: 10.12677/acm.2026.163837, PDF,   
作者: 夏继鹏, 马小萱:青岛大学青岛医学院,山东 青岛;朱荣坤, 邴春梅*:青岛大学附属医院小儿外科,山东 青岛
关键词: Castleman病儿童贫血腹痛Castleman Disease Children Anemia Abdominal Pain
摘要: 目的:探讨儿童Castleman病(CD)的临床特点,提高对该病诊断、治疗及预后的了解。方法:回顾性分析青岛大学附属医院收治的1例儿童CD患者临床及病理资料。同时检索中国知网、万方医学网、Pubmed中英文数据库对相关文献进行复习。结果:本例患儿以反复贫血及腹痛为首发症状,增强CT提示腹腔均匀强化软组织肿块影,行腹腔镜下切除手术。术后随访半年无复发。结论:儿童Castleman病较为罕见,其诊断需要结合临床、影像及病理综合判断,提高对该病的认识,有助于减少漏诊、误诊。
Abstract: Objective: To explore the clinical characteristics of Castleman disease (CD) in children and enhance understanding of its diagnosis, treatment, and prognosis. Methods: A retrospective analysis was conducted on the clinical and pathological data of a pediatric CD patient admitted to the Affiliated Hospital of Qingdao University. Additionally, relevant literature was reviewed by searching the Chinese and English databases of CNKI, Wanfang Medical Network, and PubMed. Results: This patient presented with recurrent anemia and abdominal pain as the initial symptoms. Enhanced CT scan revealed a uniformly enhanced soft tissue mass in the abdominal cavity, and laparoscopic resection was performed. Follow-up for half a year after surgery showed no recurrence. Conclusion: Castleman disease in children is relatively rare, and its diagnosis requires a comprehensive assessment of clinical, imaging, and pathological findings. Improving awareness of this disease can help reduce missed and incorrect diagnoses.
文章引用:夏继鹏, 朱荣坤, 马小萱, 邴春梅. 以反复贫血及腹痛为首发症状的一例Castleman病诊疗经过及文献复习[J]. 临床医学进展, 2026, 16(3): 690-696. https://doi.org/10.12677/acm.2026.163837

参考文献

[1] Castleman, B., Iverson, L. and Menendez, V.P. (1956) Localized Mediastinal Lymph-Node Hyperplasia Resembling Thymoma. Cancer, 9, 822-830. [Google Scholar] [CrossRef] [PubMed]
[2] 贾鸣男, 张路, 李剑. 特发性多中心型Castleman病的诊疗进展[J]. 中国肿瘤临床, 2019, 46(11): 541-545.
[3] 中华医学会血液学分会淋巴细胞疾病学组, 中国抗癌协会血液肿瘤专业委员会, 中国Castleman病协作组. 中国Castleman病诊断与治疗专家共识(2021年版) [J]. 中华血液学杂志, 2021, 42(7): 529-534.
[4] Van Rhee, F., Oksenhendler, E., Srkalovic, G., Voorhees, P., Lim, M., Dispenzieri, A., et al. (2020) International Evidence-Based Consensus Diagnostic and Treatment Guidelines for Unicentric Castleman Disease. Blood Advances, 4, 6039-6050. [Google Scholar] [CrossRef] [PubMed]
[5] Alaggio, R., et al. (2022) The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia, 36, 1720-1748.
[6] 李理, 张蕊, 王天有. Castleman病的发病机制及治疗研究进展[J]. 中国小儿血液与肿瘤杂志, 2022, 27(5): 336-339+348.
[7] Dispenzieri, A., Armitage, J.O., Loe, M.J., Geyer, S.M., Allred, J., Camoriano, J.K., et al. (2012) The Clinical Spectrum of Castleman’s Disease. American Journal of Hematology, 87, 997-1002. [Google Scholar] [CrossRef] [PubMed]
[8] 刘秀芬, 马静, 周丽娟, 等. Castleman病最新研究进展[J]. 中国医学文摘(耳鼻咽喉科学), 2019, 34(5): 360-363.
[9] 王艳龙, 徐钰欣, 孙象军. 腹膜后Castleman病10例临床与病理特征分析[J]. 中国现代普通外科进展, 2024, 27(4): 305-308.
[10] Fajgenbaum, D.C., van Rhee, F. and Nabel, C.S. (2014) HHV-8-Negative, Idiopathic Multicentric Castleman Disease: Novel Insights into Biology, Pathogenesis, and Therapy. Blood, 123, 2924-2933. [Google Scholar] [CrossRef] [PubMed]
[11] Gagliardo, C., Johnson, E. and Di Pentima, M.C. (2021) Leuconostoc lactis Sepsis in a Child with Chromosomal 18 Abnormality Receiving Enteral Nutrition. Journal of Paediatrics and Child Health, 57, 170. [Google Scholar] [CrossRef] [PubMed]
[12] Karaca, F., Usul Afşar, Ç., Erkurt, E., Arslantaş, H.S., Çalış, E., Totan Ateş, B., et al. (2014) The Role of Radiotherapy among the Therapeutic Options for Castleman’s Disease. Turkish Journal of Hematology, 31, 197. [Google Scholar] [CrossRef] [PubMed]
[13] Rose-John, S. (2012) IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of Il-6. International Journal of Biological Sciences, 8, 1237-1247. [Google Scholar] [CrossRef] [PubMed]
[14] 徐傲, 陈柯, 王琦, 等. Castleman病45例临床病理学分析[J]. 安徽医药, 2017, 21(9): 1632-1637.
[15] 刘琰婷. Castleman病的基础和临床研究[D]: [博士学位论文]. 北京: 北京协和医学院, 2025.
[16] Liu, H.L., Fan, L. and Li, J.Y. (2020) Progress in the Diagnosis and Treatment of Castleman Disease. Chinese Journal of Tuberculosis and Respiratory Diseases, 41, 697-700.
[17] Nishimoto, N., Terao, K., Mima, T., Nakahara, H., Takagi, N. and Kakehi, T. (2008) Mechanisms and Pathologic Significances in Increase in Serum Interleukin-6 (IL-6) and Soluble IL-6 Receptor after Administration of an Anti-IL-6 Receptor Antibody, Tocilizumab, in Patients with Rheumatoid Arthritis and Castleman Disease. Blood, 112, 3959-3964. [Google Scholar] [CrossRef] [PubMed]
[18] Mukherjee, S., Martin, R., Sande, B., Paige, J.S. and Fajgenbaum, D.C. (2022) Epidemiology and Treatment Patterns of Idiopathic Multicentric Castleman Disease in the Era of Il-6-Directed Therapy. Blood Advances, 6, 359-367. [Google Scholar] [CrossRef] [PubMed]